La evaluación de riesgos financieros y su efecto en la toma de decisiones en la Compañía Farmacéutica Vera S.A. "COFARVE".

Abstract

Today, in highly competitive and regulated sectors such as pharmaceuticals, financial risk assessment is essential for making strategic decisions. It is key to managing risks, complying with regulations, optimizing investments and maintaining supply chain integrity, driving sustainability and business success. Thus, the general objective of this research is: Analyze which financial risk assessment methods and tools are the most appropriate to implement in Compañía Farmacéutica Vera S.A. "COFARVE" To do this, a descriptive, deductive and analytical methodology will be applied; with a mixed approach, which includes the application of an interview to the head of the accounting department and a survey to the company's accounting staff. The results revealed that the company lacks a structured system for financial risk assessment, which limits proactive threat identification. Areas of improvement were identified and the implementation of a methodology based on method and tools such as scenario analysis and risk simulation models was recommended to improve decision making and strategic management. This will not only allow COFARVE S.A. improve your ability to anticipate risks, but also ensure regulatory compliance and strengthen your long-term success.